Hydrocortisone-Loaded Lipid-Polymer Hybrid Nanoparticles for Controlled Topical Delivery: Formulation Design Optimization and In Vitro and In Vivo Appraisal

被引:13
作者
Alsaidan, Omar Awad [1 ]
Elmowafy, Mohammed [1 ]
Shalaby, Khaled [1 ]
Alzarea, Sami I. [2 ]
Massoud, Diaa [3 ]
Kassem, Abdulsalam M. [4 ]
Ibrahim, Mohamed F. [4 ]
机构
[1] Jouf Univ, Coll Pharm, Dept Pharmaceut, Sakaka 72341, Saudi Arabia
[2] Jouf Univ, Coll Pharm, Dept Pharmacol, Sakaka 72341, Saudi Arabia
[3] Jouf Univ, Coll Sci, Dept Biol, Sakaka 72341, Saudi Arabia
[4] Al Azhar Univ, Fac Pharm Boys, Dept Pharmaceut & Pharmaceut Technol, Nasr City 68820, Cairo, Egypt
关键词
BOX-BEHNKEN DESIGN; DRUG-DELIVERY; SKIN-DISEASE; SHELL; CORE; METHOTREXATE; SURFACTANTS; FEATURES; BURDEN; IMPACT;
D O I
10.1021/acsomega.3c00638
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The barrier functionalities of the skin offer a majorbut not insuperablehindrance for fabrication of skin delivery effective systems. Thiswork aimed to develop an optimized lipid polymer hybrid nanoparticleand assess the skin delivery effectiveness of hydrocortisone (9.872 +/- 0.361 x 10(-3) cm(2)/h) of adrug through the skin from an optimized formulation when comparedwith a drug solution. Meanwhile, histological examination after topicalapplication of the optimized formulation showed a safe increase inepidermal thickness. In vivo, the optimized formulation showed promisinganti-inflammatory activity in a croton oil-induced ear rosacea model.As an excellent anti-inflammatory agent, these findings propose thatthe use of lipomers could be a promising strategy to improve the topicaleffectiveness of hydrocortisone acetate (HCA) against inflammatorydiseases. Collectively, these results support our view that lipidpolymer hybrid nanoparticles can proficiently deliver hydrocortisoneto the skin in treating skin inflammatory conditions.
引用
收藏
页码:18714 / 18725
页数:12
相关论文
共 56 条
[1]   Polymeric versus lipid nanocapsules for miconazole nitrate enhanced topical delivery: in vitro and ex vivo evaluation [J].
Abdel-Rashid, Rania S. ;
Helal, Doaa A. ;
Alaa-Eldin, Ahmed Adel ;
Abdel-Monem, Raghda .
DRUG DELIVERY, 2022, 29 (01) :294-304
[2]   Topical glucocorticoids and the skin-mechanisms of action: an update [J].
Ahluwalia, A .
MEDIATORS OF INFLAMMATION, 1998, 7 (03) :183-193
[3]   Enhanced Skin Permeation of Hydrocortisone Using Nanoemulsion as Potential Vehicle [J].
Altamimi, Mohammad ;
Haq, Nazrul ;
Alshehri, Sultan ;
Qamar, Wajhul ;
Shakeel, Faiyaz .
CHEMISTRYSELECT, 2019, 4 (34) :10084-10091
[4]  
Aulton M. E., 2017, AULTONS PHARM E BOOK
[5]   Lipomer of doxorubicin hydrochloride for enhanced oral bioavailability [J].
Benival, Derajram M. ;
Devarajan, Padma V. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2012, 423 (02) :554-561
[6]   Clinical phenotypes and endophenotypes of atopic dermatitis: Where are we, and where should we go? [J].
Bieber, Thomas ;
D'Erme, Angelo M. ;
Akdis, Cezmi A. ;
Traidl-Hoffmann, Claudia ;
Lauener, Roger ;
Schappi, Georg ;
Schmid-Grendelmeier, Peter .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (04) :S58-S64
[7]   EFFECT OF NONIONIC SURFACTANTS ON TRANSDERMAL DRUG DELIVERY .1. POLYSORBATES [J].
CAPPEL, MJ ;
KREUTER, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 69 (02) :143-153
[8]   Transdermal iontophoretic delivery of hydrocortisone from cyclodextrin solutions [J].
Chang, SL ;
Banga, AK .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1998, 50 (06) :635-640
[9]  
Chen Y, 2017, DEVELOPING SOLID ORAL DOSAGE FORMS: PHARMACEUTICAL THEORY AND PRACTICE, 2ND EDITION, P637, DOI 10.1016/B978-0-12-802447-8.00023-6
[10]   Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles [J].
Cheow, Wean Sin ;
Hadinoto, Kunn .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 85 (02) :214-220